Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
American Heart Journal
|
November 26, 2013
Design and methods of European Ambulance Acute Coronary Syndrome Angiography Trial (EUROMAX): an international randomized open-label ambulance trial of bivalirudin versus standard-of-care anticoagulation in patients with acute ST-segment-elevation myocardial infarction transferred for primary percutaneous coronary intervention
Philippe Gabriel Steg, Arnoud van 't Hof, Peter Clemmensen, et al.
Circulation
|
August 29, 2017
Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015
Etienne Puymirat, Tabassome Simon, Guillaume Cayla, et al.
Thrombosis and Haemostasis
|
December 11, 2019
Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and Methodology
Behnood Bikdeli, Thomas McAndrew, Aaron Crowley, et al.
Circulation
|
July 13, 2023
STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial
Frans Van de Werf, Arsen D Ristić, Oleg V Averkov, et al.
The New England Journal of Medicine
|
November 1, 2013
Bivalirudin started during emergency transport for primary PCI
Philippe Gabriel Steg, Arnoud van 't Hof, Christian W Hamm, et al.
The Journal of Clinical Psychiatry
|
September 27, 2018
Combining Postcards, Crisis Cards, and Telephone Contact Into a Decision-Making Algorithm to Reduce Suicide Reattempt: A Randomized Clinical Trial of a Personalized Brief Contact Intervention
Guillaume Vaiva, Sofian Berrouiguet, Michel Walter, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 18, 2016
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations
J Wouter Jukema, Maddalena Lettino, Petr Widimský, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 18, 2016
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries
Nicolas Danchin, Maddalena Lettino, Uwe Zeymer, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
March 23, 2017
Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes
Maddalena Lettino, Pontus Andell, Uwe Zeymer, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 18, 2016
P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries
Uwe Zeymer, Petr Widimsky, Nicolas Danchin, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
American Heart Journal
|
November 26, 2013
Design and methods of European Ambulance Acute Coronary Syndrome Angiography Trial (EUROMAX): an international randomized open-label ambulance trial of bivalirudin versus standard-of-care anticoagulation in patients with acute ST-segment-elevation myocardial infarction transferred for primary percutaneous coronary intervention
Philippe Gabriel Steg, Arnoud van 't Hof, Peter Clemmensen, et al.
Circulation
|
August 29, 2017
Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015
Etienne Puymirat, Tabassome Simon, Guillaume Cayla, et al.
Thrombosis and Haemostasis
|
December 11, 2019
Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and Methodology
Behnood Bikdeli, Thomas McAndrew, Aaron Crowley, et al.
Circulation
|
July 13, 2023
STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial
Frans Van de Werf, Arsen D Ristić, Oleg V Averkov, et al.
The New England Journal of Medicine
|
November 1, 2013
Bivalirudin started during emergency transport for primary PCI
Philippe Gabriel Steg, Arnoud van 't Hof, Christian W Hamm, et al.
The Journal of Clinical Psychiatry
|
September 27, 2018
Combining Postcards, Crisis Cards, and Telephone Contact Into a Decision-Making Algorithm to Reduce Suicide Reattempt: A Randomized Clinical Trial of a Personalized Brief Contact Intervention
Guillaume Vaiva, Sofian Berrouiguet, Michel Walter, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 18, 2016
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations
J Wouter Jukema, Maddalena Lettino, Petr Widimský, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 18, 2016
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries
Nicolas Danchin, Maddalena Lettino, Uwe Zeymer, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
March 23, 2017
Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes
Maddalena Lettino, Pontus Andell, Uwe Zeymer, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 18, 2016
P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries
Uwe Zeymer, Petr Widimsky, Nicolas Danchin, et al.
Page
of 10